Abstract. Estrogen has an important effect on higher brain function such as memory, learning, and emotion in which the hippocampus plays a critical role. The hippocampus expresses estrogen receptors, ERα and ERβ, which are liganddependent transcription factors; however, the precise mechanism of estrogen action is not fully understood. We explored genes which are up-regulated by estrogen in the hippocampus using ovariectomized rat models. Microarray analysis revealed that mRNA levels of ectonucleotide pyrophosphatase/phosphodiesterase 2 (Enpp2), insulin like growth factor 2 (Igf2) and insulin-like growth factor binding protein 2 (Igfbp2) were increased by estrogen in the hippocampus. Quantitative-PCR analysis demonstrated that the levels of Enpp2, Igf2 and Igfbp2 mRNA were elevated by estrogen administration in the hippocampus but not in the hypothalamus. On the other hand, ERα, ERβ and progesterone receptor (PR) mRNA expression was up-regulated by estrogen only in the hypothalamus. We further analyzed the time-dependent regulation of these genes using rat pituitary adenoma, MtT/S and GH3 cells, which are known to express ERα. In both MtT/S and GH3 cells, Igfbp2 and Enpp2 mRNAs were up-and down-regulated by estrogen, respectively, whereas Igf2 mRNA was increased only in GH3 cells. These results demonstrate a brain region-and cell type-specific responses to estrogen in rat brain, suggesting that Igf signaling may mediate the estrogen function in the hippocampus.
ESTROGEN, a sex steroid hormone, plays a critical role in central nervous system as well as reproductive organ. Especially, epidemiological predominance of Alzheimer's disease and emotional disorder in postmenopausal women supports the clinical relevance of estrogen function in the brain [1] [2] [3] . However, therapeutic effects of estrogen for neuronal diseases have not been established because several studies reveal that estrogen replacement therapy does not slow the Alzheimer's disease progression nor improve cognitive or functional outcomes [4, 5] . Since the hippocampus has a central role in the regulation of higher brain function, such as memory, learning, and emotion [6] , analysis of estrogen function in the hippocampus would help to resolve these contradictory issues and provide new therapeutic insights into such diseases. Several effects of estrogen have been reported in hippocampal neurons [7] . For instance, estrogen increases cyclic synaptogenesis on hippocampal neurons and induces spines on dendrites of dissociated hippocampal neurons in culture. However, precise mechanism of estrogen regulation in the hippocampus is not fully understood.
Estrogen exerts its physiological function through binding with estrogen receptors, ERα and ERβ [8] . The ERs are ligand-dependent transcription factors of nuclear receptor superfamily. Thus, estrogen responsive genes mediate physiological function of estrogen in target cells. In the brain, it is known that the hypothalamus, which plays crucial roles in the regulation of sexual behavior and secretion of endocrine hormones, abundantly expresses ERα [9] . Multiple analyses have been carried out to identify the estrogen responsive genes including N-methyl-D-aspartate (NMDA) receptor type 2D (NR2D) [10] and GABA(A) receptor-associated protein like 1 (gec-1) [11] in the hypothalamus. On the other hand, downstream target genes of estrogen remain to be elusive in hippocampus where ERs are expressed with modest levels.
In the present study, estrogen responsive genes in rat hippocampus were investigated using microarray and quantitative PCR analyses. Ectonucleotide pyrophosphatase/phosphodiesterase 2 (Enpp2), insulin like growth factor 2 (Igf2), and insulin-like growth factor binding protein 2 (Igfbp2) genes were demonstrated to be up-regulated by estrogen in the hippocampus but not in the hypothalamus. Meanwhile, estrogen stimulation of ERs and progesterone receptor (PR) mRNAs was observed in the hypothalamus but not in the hippocampus. In addition, these estrogen responsive genes and ERs were regulated by estrogen in a cell type-specific manner. These observations suggested that the hippocampal specific estrogen responsive genes may be involved in higher brain function.
Materials and Methods

RNA isolation from estrogen-treated rat brain and rat pituitary tumor cell lines
All experiments involving animals were approved by the Institutional Animal Care and Use Committee. Female Wistar rats (8 week old) were divided into three groups. The first group of rats (n = 10) was ovariectomized for 2 weeks and then subcutaneously administrated with 17β-estradiol (10 μg/kg) (Ovx + E). The second group of rats (n = 10) was ovariectomized as above and then subcutaneously administrated with olive oil as vehicle (Ovx + V). The last group of rats (n = 10) was sham-operated for 2 weeks (Sham). After 8 hours from the injection of 17β-estradiol (Ovx + E group) or vehicle (Ovx + V group), animals were sacrificed to isolate the hippocampus and hypothalamus. At the same time course, these two tissues from rats of Sham group administered with vehicle were also isolated. The hippocampus and hypothalamus from Ovx + E, Ovx + V and Sham groups were pooled from ten animals, respectively, and subjected to isolation of Poly(A)+ RNA by Oligotex-dT30 mRNA Purification Kit (TAKARA, Tokyo, Japan).
Rat pituitary tumor cell lines, GH3 and MtT/S, were obtained from Health Science Research Resources Bank and Riken BioResource Center, respectively [12, 13] . Cells were maintained in a half and half mixture of Dulbecco's modified Eagle's medium (DMEM) and F-12 medium supplemented with 2.5% fetal bovine serum (FBS) and 10% horse serum at 37°C in 5% CO 2 and a humidified atmosphere. Before estrogen treatment, cells were transferred to phenol red-free DMEM in which the FCS was stripped with dextran-coated charcoal (dccFCS), to remove all estrogenic influences. After two days of estrogen deprivation, cells were administered with 10 nM 17β-estradiol, and incubated for 2, 12 and 24 h. Total RNAs of these estrogen-stimulated cells were isolated using ISOGEN reagent (NIPPONGENE, Tokyo, Japan) according to the manufacturer's instruction.
Microarray Analysis
Hippocampal Poly(A)+ RNAs extracted from Ovx + E and Ovx + V groups were used for synthesis of cDNAs and biotin-labeled cRNAs were prepared according to the Affymetrix technical manual (Affymetrix, Santa Clara, CA). The biotinilated cRNA (5 μg per array) was hybridized to Affymetrix Rat Neurobiology U34 Arrays containing oligonucleotide probe sets representing approximately 1,200 neurobiology-related genes. Hybridization, washing, and staining of Rat Neurobiology U34 Arrays were carried out according to the Affymetrix technical manual in an Affymetrix hybridization oven and fluidics station. The arrays were scanned using an Agilent GeneArray Scanner (Agilent Technologies, Santa Clara, CA). Expression values were globally normalized and compared across the samples using Affymetrix Microarray Suit 5.0 Software (Affymetrix, Santa Clara, CA).
Quantitative PCR
Real-time quantitative PCR (qPCR) was performed using an ABI Prism 7000 sequence detection system (Applied Biosystems) using SYBR Green as a fluorescence probe [14] . The sequences of primers are as follows: Enpp2 (forward: 5'-GGTCCCCTCTCTGTGTC TTCCT-3'; reverse: 5'-CGACTCATCCTCGGAGCT ATTAC-3'); Igf2 (forward: 5'-TGTCTACCTCTCAG GCCGTACTT-3'; reverse: 5'-TCCAGGTGTCGAAT TTGAAGAA-3'); Igfbp2 (forward: 5'-CCTGCATAT CCCCAACTGTGA-3'; reverse: 5'-CGCTGTCCATT CAGAGACATCT-3'); ERα (forward: 5'-CCACCGA GTCCTGGACAAGA-3'; reverse: 5'-TGCAGAGTC AGGCCAGCTT-3'); ERβ (forward: 5'-GAGGTGCT AATGGTGGGACTG-3'; reverse: 5'-CGAGGTCGG GAGCGAAA-3'); PR (forward: 5'-TGCAGGGCATG ACAACACA-3'; reverse: 5'-CTGCCTCTCGCCTAG TTGGTT-3'); and L19 (forward: 5'-GGTCAAAGGG AATGTGTTCAA-3'; reverse: 5'-GGGCCTTGTCTG CCTTCAG-3'). One microgram of poly(A)+ RNAs from the hippocampus and hypothalamus of Sham, Ovx + V and Ovx + E groups, and one microgram of total RNAs from estrogen-stimulated GH3 and MtT/S cells was reverse-transcribed using poly(dT)20 primer and SuperScript II (Invitrogen). The reaction mixture for qPCR was performed with 1.5% of reverse-transcribed product in the presence of 1× master mix reagents (3.5 mM MgCl 2 , 300 μM deoxynucleoside-5'-triphosphate, 0.25 IU hot goldStart enzyme, and SYBR Green) (Applied Biosystems). qPCR analysis was performed for 40 cycles for all target genes as well as L19 cDNA amplification to normalize RNA loading. The results were shown as means ± SD from triplicated experiments. Statistical analysis of means between groups/treatments was performed by Student's t-test.
Results
Identification of genes regulated by estrogen in rat hippocampus
To explore the estrogen regulation of genes in the hippocampus, we employed an ovariectomized rat model following estrogen administration, namely, rats were ovariectomized for 2 weeks and then administered with 10 μg/kg 17β-estradiol (Ovx + E) or vehicle (Ovx + V). This dose of estrogen used here could raise its concentration to proestrus levels in blood which is sufficient to induce physiological responses such as increase of uterine weight and c-Fos expression in the brain as a marker of neuronal activation [15] . Poly(A)+ RNAs were isolated from the hippocampus of these animals 8 h after estrogen injection and subjected to microarray analysis using Affymetrix Rat Neurobiology U34 array, which contains over 1,200 sequences relevant to the study of neurobiology. Resulting signals were normalized and represented as fold change over vehicle control (Table 1) . Table 1 shows the 3 and 13 genes that demonstrated expression ratios of above 1.7 and below 0.6, respectively, after estrogen administration in rat hippocampus. In this experiment, the top three up-regulated genes (Enpp2, Igf2 and Igfbp2) were newly identified as estrogen responsive genes in rat hippocampus. Thus, we further analyzed the estrogen responsiveness of these genes in rat brain and in brain-derived culture cell lines.
Differential regulation of
In addition to the hippocampus, the hypothalamus is also considered as one of the target sites for estrogen in the brain. Thus, we investigated the estrogen regulation of Enpp2, Igf2 and Igfbp2 mRNA expression in hippocampus comparing with the hypothalamus. As a control, sham-operated rats were administered with vehicle (Sham) and the poly(A)+ RNAs from the hippocampus and hypothalamus were subjected to this experiment. Besides, estrogen receptors (ERα and ERβ) and PR, which has been shown as an estrogen responsive gene in rat hypothalamus, were also examined at the same time. Estrogen-dependent expression of these genes in the hippocampus and hypothalamus were evaluated by qPCR analysis using specific primers ( Fig. 1 and Table 2 ). The expression levels of Enpp2, Igf2 and Igfbp2 mRNA were relatively high in both the hippocampus and hypothalamus compared with a control ribosomal protein L19. In the hippocampus, Ovx decreased mRNA expressions of Enpp2, Igf2, and Igfbp2 genes compared with Sham, and estrogen administration increased expression of the three genes to almost similar levels in Sham (Fig. 1A) . On the other hand, in the hypothalamus, mRNA levels of these genes showed no change between Ovx + E Fig. 1 . Differential estrogen regulation of Enpp2, Igf2, Igfbp2, ERα, ERβ and PR mRNAs in rat hippocampus and hypothalamus. Ovariectomized rats were administered with 10 μg/kg of 17β-estradiol (Ovx + E) or vehicle (Ovx + V), and sham-operated rats were administered with vehicle (Sham). After 8 h, the hippocampus (A) and hypothalamus (B) were isolated from the three groups, and poly(A)+ RNAs were extracted to synthesize cDNA. mRNA expression levels of each gene were examined by real-time quantitative PCR (qPCR) and the results were shown as fold change over the expression level of Sham. Each expression level was statistically compared with the corresponding control in Ovx + V group. *P<0.05; **P<0.01. and Ovx + V groups (Fig. 1B ). Moreover, Igfbp2 expression level in Ovx + V was elevated in the hypothalamus compared with Sham. This result demonstrated that Enpp2, Igf2 and Igfbp2 mRNAs are positively regulated by estrogen in the hippocampus but not in the hypothalamus. In the hippocampus, estrogen treatment did not significantly alter the mRNA levels of ERα and ERβ, whereas the level of PR was down-regulated by estrogen (Fig. 1A) . On the contrary, mRNA expressions of ERα, ERβ and PR were significantly elevated in the hypothalamus treated with Ovx + E compared with Ovx + V (Fig. 1B) . These results show that there is a brain region-specific difference of estrogen-dependent expression of ERs and estrogen responsive genes between the hippocampus and hypothalamus.
Estrogen regulation of Enpp2, Igf2, Igfbp2, ERα, ERβ and PR mRNA expression in rat pituitary cell lines
Next, we analyzed the time-dependent estrogen responsiveness of Enpp2, Igf2, Igfbp2, ERα, ERβ and PR genes using cultured cells. Because of the limited availability of rat neural cell lines that express endogenous ERs abundantly, we utilized ERα-positive MtT/S and GH3 cells [12, 13] established from rat pituitary tumors with secretion of growth hormone. qPCR was performed using cDNAs prepared from the cells with or without estrogen treatment at a physiological concentration (10 nM) [16] , and fold changes of mRNA amounts and the absolute values were represented in Fig. 2 and Table 2 , respectively. As shown in Table 2 , Igf2 and Igfbp2 mRNAs were more abundantly expressed in MtT/S cells than GH3 cells. Besides, MtT/S cells have much higher mRNA content of ERα than ERβ, whereas GH3 cells contain similar levels of them. Up-regulation of Igfbp2 mRNA and downregulation of Enpp2 mRNA were commonly observed in MtT/S and GH3 cells, namely, Igfbp2 mRNA expression was increased at 12 and 24 h after estrogen treatment both in MtT/S and GH3 cells, and Enpp2 mRNA was decreased at 2 or 24 h after estrogen treatment in MtT/S or GH3 cells, respectively (Fig. 2) . However, Igf2 mRNA expression was up-regulated by estrogen at 24 h only in GH3 cells. Relative amounts of ERα and ERβ mRNA were elevated by estrogen in MtT/S cells, whereas those were reduced in GH3 cells. The mRNA expression of PR was positively regulated under estrogen treatment both in MtT/S and GH3 cells.
Taken together, these results showed the estrogendependent cell type-specific regulations of gene expression regarding estrogen receptors and estrogen target genes.
Discussion
In the present study, we demonstrated that Igf2, Igfbp2 and Enpp2 are estrogen responsive genes in rat hippocampus, but not in hypothalamus. In contrast, the elevation of ERα, ERβ and PR mRNAs has been shown in the hypothalamus, which is not observed in the hippocampus in response to estrogen. Interestingly, the estrogen responsiveness in regard to these genes could be also variable in rat pituitary cell lines. These results reveal that the expression of estrogen- related genes can be varied in cell type-and brain region-specific manners. We identify that putative estrogen-responsive elements (ERE) are located in intron1 of Igf2 (GGGGCAtcgTGACCT) and 5'-UTR of Igfbp2 (GGGTGActgTGACCG). We can speculate that these ERE-like sequences might be involved in the estrogen-dependent transcriptional regulation of Igf2 and Igfbp2 mRNA. Although the mechanism underlying the hippocampus-specific estrogen-dependent regulation of gene expression remains to be elusive, it is possible that other brain region-specific transcription factors also contribute to the regulation of the genes together with estrogen receptors. It is considered that estrogen can cross the blood brain barrier as a small liophilic compound, and effect on brain functions including sexual behavior and neuroprotection by regulating the target gene expression through ER [17] . Indeed, in our experiments, subcutaneously administered estrogen increased the mRNA level of PR which is shown as an estrogen responsive gene within both the medial preoptic nucleus (MPN) and the ventromedial nucleus (VMN) of the hypothalamus [18] . Our results suggest that peripheral estrogen can translocate to the target regions in the brain and directly modulate the gene expression. Nevertheless, it does not exclude the possibility that estrogen synthesized in the brain itself exerts such specific function in the local brain region [19] .
Igf2, a member of the insulin gene family, is known to be important for brain development and to have neurotrophic or neuroprotective properties [20, 21] . Igf receptors are also expressed throughout the CNS. Especially, Igf2 receptor is mainly present in the hippocampus, suggesting that this brain region would be an important target for Igf2 action [22] . Igf binding proteins are thought to modulate the biological actions of the Igf. In particular, Igfbp2 is assumed to play a dominant role in the regulation of Igf in the CNS because Igfbp2 is the most abundant Igfbp expressed in the brain [23, 24] . Since Igf/Igfbp2 protein complex is shown to have a marked affinity for extra cellular matrix, potentially retaining Igf bioactivity within the target tissue [25] , we speculate that Igf2 and Igfbp2 may stimulate Igf signaling in response to estrogen in the hippocampus.
Reduced expression of insulin, Igf1, and Igf2 and their abnormal signaling have been found in Alzheimer's disease [26] . Moreover, insulin and Igf1 are assumed to modulate brain levels of insulin degrading enzyme, which leads to an accumulation of amyloid β [27] . In rat kinic acid-induced insult model of hippocampal lesion, the neuroprotective effect of 17β-estradiol depends both on estrogen receptors and Igf1 receptors, while the protection exerted by Igf1 depends also on estrogen receptors [28] . Although it is still controversial whether hormone replacement therapy has positive or negative effects on cognition as well as the prevention for neurodegenerataion [4, 5] , yet, estrogen would affect brain function through modulating the Igf signaling.
In the present study, Enpp2 has been also identified as an estrogen-responsive gene in rat hippocampus. Enpp2 has an activity of phosphodiestrase and an effect on neuronal plasticity in the CNS [29] . Therefore, our results suggest that Igf2, Igfbp2, and Enpp2 may mediate estrogen actions such as neuroprotection and synaptic plasticity in the hippocampus. Further investigation concerning the relationship between ER and Igf signalings will provide new insight into the higher brain function and neuronal diseases.
